NEUROENDOCRINE TUMOUR OF THE RECTUM

NEUROENDOCRINE TUMOUR OF THE RECTUM was reported 32 times

NEUROENDOCRINE TUMOUR OF THE RECTUM is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PEGFILGRASTIM-JMDB 1 0.0022
1 LUTETIUM LU 177 DOTATATE 12 0.0021
2 OCTREOTIDE ACETATE 10 0.0003
3 LANREOTIDE ACETATE 2 0.0003
4 EVEROLIMUS TABLETS 4 0.0002
5 EVEROLIMUS 11 0.0002
6 PALONOSETRON HYDROCHLORIDE 1 0.0002
7 PEGFILGRASTIM 1 0.0001
8 DURVALUMAB 1 0.0000
9 BELIMUMAB 1 0.0000
10 LIRAGLUTIDE 1 0.0000
11 LAMOTIRIGINE 1 0.0000
12 LAMOTRIGINE CHEWABLE DISPERSIBLE 1 0.0000
13 ORAL SEMAGLUTIDE 1 0.0000
14 HYDROMORPHONE HYDROCHLORIDE 1 0.0000
15 LAMOTRIGINE 1 0.0000
16 TIRZEPATIDE 1 0.0000